Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic.

Røe OD, Stella GM.

Eur Respir Rev. 2015 Mar;24(135):115-31. doi: 10.1183/09059180.00007014. Review.

2.

The role of polio-vaccine in pleural mesothelioma--an epidemiological observation.

Sarić M, Curin K, Varnai VM.

Coll Antropol. 2008 Jun;32(2):479-83.

PMID:
18756898
3.

Simian virus 40 and mesothelioma in Great Britain.

Price MJ, Darnton AJ, McElvenny DM, Hodgson JT.

Occup Med (Lond). 2007 Dec;57(8):564-8. Epub 2007 Aug 4.

4.

SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen.

Lowe DB, Shearer MH, Jumper CA, Kennedy RC.

Cell Mol Life Sci. 2007 Apr;64(7-8):803-14. Review.

PMID:
17260087
5.

SV40 and human cancer: a review of recent data.

Shah KV.

Int J Cancer. 2007 Jan 15;120(2):215-23. Review.

6.

Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40.

Leithner K, Leithner A, Clar H, Weinhaeusel A, Radl R, Krippl P, Rehak P, Windhager R, Haas OA, Olschewski H.

Orphanet J Rare Dis. 2006 Nov 7;1:44.

7.

Is there a role for SV40 in human cancer?

Poulin DL, DeCaprio JA.

J Clin Oncol. 2006 Sep 10;24(26):4356-65. Review.

PMID:
16963733
8.

Limitations of epidemiological and serologic studies addressing simian virus 40 and non-Hodgkin's lymphoma.

Vilchez RA.

Cancer Invest. 2006 Apr-May;24(3):333-6. No abstract available.

PMID:
16809164
9.

High prevalence of SV40 infection in patients with nodal non-Hodgkin's lymphoma but not acute leukemia independent of contaminated polio vaccines in Taiwan.

Chen PM, Yen CC, Yang MH, Poh SB, Hsiao LT, Wang WS, Lin PC, Lee MY, Teng HW, Bai LY, Chu CJ, Chao SC, Yang AH, Chiou TJ, Liu JH, Chao TC.

Cancer Invest. 2006 Apr-May;24(3):223-8.

PMID:
16809147
10.

[Poliomyelitis vaccine contaminated with SV40 and prior exposure to asbestos: cognitive study in a group of car repair workers].

Poti S, Bellomo RK, Di Pierri C, L'Abbate N.

G Ital Med Lav Ergon. 2006 Apr-Jun;28(2):168-9. Italian.

PMID:
16805449
11.

Polio vaccines, SV40 and human tumours, an update on false positive and false negative results.

Elmishad AG, Bocchetta M, Pass HI, Carbone M.

Dev Biol (Basel). 2006;123:109-17; discussion 119-32.

PMID:
16566440
12.

SV40, genetic polymorphism and mesothelioma. pathological and epidemiological evidence.

Magnani C.

Med Lav. 2005 Jul-Aug;96(4):347-53. Review.

PMID:
16457431
13.

Lymphoproliferative disorders in Costa Rica and simian virus 40.

Meneses A, Lopez-Terrada D, Zanwar P, Killen DE, Monterroso V, Butel JS, Vilchez RA.

Haematologica. 2005 Dec;90(12):1635-42.

14.

Simian virus 40 and lymphoproliferative disorder.

Della Porta MG, Malcovati L.

Haematologica. 2005 Dec;90(12):1587. No abstract available.

PMID:
16330424
15.
16.
17.

Absence of simian virus 40 (SV40) DNA in lymphoma samples from Tasmania, Australia.

Sui LF, Williamson J, Lowenthal RM, Parker AJ.

Pathology. 2005 Apr;37(2):157-9.

PMID:
16028845
18.
19.

Simian virus 40 and human disease.

Shah KV.

J Infect Dis. 2004 Dec 15;190(12):2061-4. Epub 2004 Nov 16. Review. No abstract available.

20.

Investigation of simian virus 40 large T antigen in 18 autopsied malignant mesothelioma patients in Japan.

Jin M, Sawa H, Suzuki T, Shimizu K, Makino Y, Tanaka S, Nojima T, Fujioka Y, Asamoto M, Suko N, Fujita M, Nagashima K.

J Med Virol. 2004 Dec;74(4):668-76.

PMID:
15484269
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk